![](https://unicorn-nest.com/wp-content/uploads/2021/11/Cambridge-Innovation-Capital.jpg?x55332)
In 2013 was created Cambridge Innovation Capital, which is appeared as VC. The main office of represented VC is situated in the Cambridge. The company was established in Europe in United Kingdom.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Cambridge Innovation Capital, startups are often financed by Parkwalk Advisors, Cambridge Angels group, University of Cambridge Enterprise. The meaningful sponsors for the fund in investment in the same round are Amadeus Capital Partners, IQ Capital, Escala Capital. In the next rounds fund is usually obtained by Martlet, Innovate UK, Amadeus Capital Partners.
The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Origami Energy, Gyroscope Therapeutics, Carrick Therapeutics. We can highlight the next thriving fund investment areas, such as Information Technology, Medical Device. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
We also calculated 10 valuable employees in our database.
This Cambridge Innovation Capital works on 25 percentage points less the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 24 percentage points more often commits exit comparing to other companies. The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2016. The fund is generally included in 7-12 deals every year. The typical startup value when the investment from Cambridge Innovation Capital is 100-500 millions dollars.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Phosphor AI | $2M | 04 Jan 2024 | Hong Kong, Hong Kong, China | ||
T-Therapeutics | $65M | 15 Nov 2023 | Cambridge, Cambridgeshire, United Kingdom | ||
Riverlane | $20M | 24 Apr 2023 | Cambridge, England, United Kingdom | ||
Complement Therapeutics | $84M | 17 Apr 2023 | London, England, United Kingdom | ||
Mosaic Therapeutics | $28M | 04 Apr 2023 | Cambridge, Cambridgeshire, United Kingdom | ||
Seldon | $20M | 16 Mar 2023 | London, England, United Kingdom | ||
Storm Therapeutics | $30M | 14 Dec 2022 | Cambridge, England, United Kingdom | ||
Carrick Therapeutics | $60M | 01 Dec 2022 | Dublin, County Dublin, Ireland | ||
Cambridge GaN Devices | $19M | 11 Nov 2022 | Cambridge, Cambridgeshire, United Kingdom |
– PetMedix, a Cambridge UK-based animal health company, raised $37M in Series B funding.
– The round was led by Tencent and Kyoritsu Holdings with participation from Digitalis Ventures, Parkwalk Advisors and Cambridge Innovation Capital.
– The company intends to use the funds to advance its innovative pipeline through clinical development.
– CMR Surgical is a Cambridge UK-based surgical robotic company.
– Series D $600M round was led by SoftBank Vision Fund 2 with participation from Ally Bridge Group, new investors RPMI Railpen, Tencent and Chimera, and existing investors LGT and its affiliate impact investing platform Lightrock, Watrium, Cambridge Innovation Capital, PFM Health Sciences and GE Healthcare.
– The investment will be used for the global commercialization of Versius and further develop the company’s digital ecosystem.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Phosphor AI | $2M | 04 Jan 2024 | Hong Kong, Hong Kong, China | ||
T-Therapeutics | $65M | 15 Nov 2023 | Cambridge, Cambridgeshire, United Kingdom | ||
Riverlane | $20M | 24 Apr 2023 | Cambridge, England, United Kingdom | ||
Complement Therapeutics | $84M | 17 Apr 2023 | London, England, United Kingdom | ||
Mosaic Therapeutics | $28M | 04 Apr 2023 | Cambridge, Cambridgeshire, United Kingdom | ||
Seldon | $20M | 16 Mar 2023 | London, England, United Kingdom | ||
Storm Therapeutics | $30M | 14 Dec 2022 | Cambridge, England, United Kingdom | ||
Carrick Therapeutics | $60M | 01 Dec 2022 | Dublin, County Dublin, Ireland | ||
Cambridge GaN Devices | $19M | 11 Nov 2022 | Cambridge, Cambridgeshire, United Kingdom |